Brief: Radiopharm Theranostics Says Rad Granted Us FDA Fast Track For Rad101 Metastases Imaging
11/06/2025 02:33
June 11 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RAD GRANTED US FDA FAST TRACK FOR RAD101 METASTASES IMAGING Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%